Loading...
XT logo

iShares Trust - iShares Future Exponential Technologies ETFInforme acción NasdaqGM:XT

Capitalización bursátil US$3.9b
Precio de las acciones
US$82.28
Mi valor justo
No disponible
1Y30.8%
7D2.3%
1D
Valor de la cartera
​
Ver

iShares Trust - iShares Future Exponential Technologies ETF

Informe acción NasdaqGM:XT

Capitalización de mercado: US$3.9b

iShares Trust - iShares Future Exponential Technologies ETF (XT) Resumen de Acciones

iShares Trust - iShares Future Exponential Technologies ETF es un fondo cotizado en bolsa lanzado por BlackRock, Inc. Saber más

Análisis fundamental de XT
Puntuación del snowflake
Valoración0/6
Crecimiento futuro0/6
Rendimiento pasado0/6
Salud financiera0/6
Dividendos2/6

XT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Competidores de iShares Trust - iShares Future Exponential Technologies ETF

 
 
 
 
 
 
 
 
 
 
 
 

Historial de precios y rendimiento

Resumen de las cotizaciones máximas, mínimas y variaciones del iShares Trust - iShares Future Exponential Technologies ETF
Precios históricos de las acciones
Precio actual de la acciónUS$82.28
Máximo en las últimas 52 semanasUS$84.23
Mínimo de 52 semanasUS$62.03
Beta0
Cambio en 1 mes3.99%
Variación en 3 meses19.33%
Cambio de 1 año30.79%
Variación en 3 años48.38%
Variación en 5 años31.94%
Variación desde la OPV219.53%

Noticias y actualizaciones recientes

Seeking Alpha • Apr 10

XT: More Sensitive Than General Market To Cost Of Capital Changes

Summary The iShares Future Exponential Technologies ETF is highly sensitive to cost of capital shifts, driven by its tech and disruptor focus, also with a lot of high-multiple healthcare. XT's global diversification does not mitigate its vulnerability to rising rates and geopolitical risks, especially from the Iran conflict, which is having a global upward cost of capital shift effect. XT is less concentrated in mega-cap US tech than IVV, but its higher IT and healthcare exposure increases sensitivity to inflation and capital costs and maintains sensitivity to overbuild risks. We see more risks than supports for XT, given fragile geopolitics and amplified yield curve sensitivity. Lower multiple alternatives in equity markets often present less cost of capital sensitivity. Read the full article on Seeking Alpha
Seeking Alpha • Oct 06

XT: An Undervalued Portfolio Of Innovative Global Tech Stocks

Summary iShares Exponential Technologies ETF focuses on companies driving technological innovation across various sectors, offering diversified exposure to high-growth potential industries. The ETF's investment thesis is centered on capturing the growth of exponential technologies, including AI, robotics, and biotechnology, which are expected to transform industries. The fund looks appealing due to its diversified portfolio, evidential capacity to out-perform (albeit not since January 2021), and alignment with long-term technological trends. At present, XT has clear potential for a high IRR, with the potential for returns of circa 11% annualized over the next five years. Read the full article on Seeking Alpha
Seeking Alpha • Jun 07

XT Will Likely Continue Lagging The Broader IT Sector

Summary iShares Exponential Technologies ETF is a hold due to multiple risk factors outweighing its returns along with a relatively high expense ratio. XT lacks holdings with strong fundamentals and diversified revenue streams compared to peer tech funds, particularly Vanguard's VGT. XT also includes foreign tech holdings in emerging markets, representing geopolitical risks. Read the full article on Seeking Alpha
Seeking Alpha • Mar 10

XT: Still Beating ARKK At Its Own Game, Upgrade To Buy For Possible Moonshot

Summary iShares Exponential Technologies ETF is a go-to holding due to market volatility and potential for high returns. I prefer XT to the ARK Innovation ETF, given its smoother path due to a more diversified and passive/indexed approach. XT's lower volatility and diversified portfolio make it a buy, with potential for a price increase to its 2022 high and beyond. Read the full article on Seeking Alpha
Seeking Alpha • Aug 07

XT: We're Going To Think Twice About This ETF

XT is pretty interesting and tackles an area of the market that has received flak in the latest sell-offs. However, we have some concerns about approaching emerging technologies with ETFs. Also the fund isn't that discounted despite expected reflexivity effects. Might get better bets with specific stocks. The iShares Exponential Technologies ETF (XT) might seem broadly interesting at first, but we have some misgivings about the concept of investing in ETFs of higher risk businesses. Moreover, we are surprised by how well the ETF has done all things considered, and worry that some latent effects might still hit it. Otherwise, we are pretty convinced of the appeal of tech in the current market, and feel that in general it should be studied by retail investors. But we would think twice about XT. Quick Breakdown First let's discuss some of the features of XT. The mandate is to build a portfolio that weights towards a decent amount of emerging markets and emerging technologies that follow nine key themes. XT Nine Areas of Focus (iShares.com) The themes listed above are pretty basic to be honest. We all know of the potential in these fields, and in the majority of cases the value of things like cloud computing have already been realised, at least in terms of priced in value, by large corporations through already profitable operations. Essentially, what XT is doing is allocating to all the sexiest ideas in investing that VCs would typically be focusing on. As mentioned it's not all US markets with only 62% allocation, which is nice because foreign markets typically don't value tech nearly as highly as the US does, and it's mostly tech but also some healthcare exposures, especially biotechs. The fee is below 0.5%, which isn't bad relative to some of these more 'exciting' ETFs. The fact sheet says that it's cheaper than 91% of ETFs in its category, but this should be taken with a grain of salt because they decide the categories. What matters is many iShares ETFs are around 0.4%, so just below 0.5% isn't bad relatively. ETFs and Exponential Technologies However, we have some comments about the ETF. The first is that the kinds of businesses it invests in, especially in healthcare, are stocks that depend reflexively on the equity capital market conditions. If their stocks decline, the cost of their financing rises. This is obviously bad because in unstable markets like the current one, where rates will have to rise a lot more to deal with inflation, because it causes vicious spirals.

Recent updates

Seeking Alpha • Apr 10

XT: More Sensitive Than General Market To Cost Of Capital Changes

Summary The iShares Future Exponential Technologies ETF is highly sensitive to cost of capital shifts, driven by its tech and disruptor focus, also with a lot of high-multiple healthcare. XT's global diversification does not mitigate its vulnerability to rising rates and geopolitical risks, especially from the Iran conflict, which is having a global upward cost of capital shift effect. XT is less concentrated in mega-cap US tech than IVV, but its higher IT and healthcare exposure increases sensitivity to inflation and capital costs and maintains sensitivity to overbuild risks. We see more risks than supports for XT, given fragile geopolitics and amplified yield curve sensitivity. Lower multiple alternatives in equity markets often present less cost of capital sensitivity. Read the full article on Seeking Alpha
Seeking Alpha • Oct 06

XT: An Undervalued Portfolio Of Innovative Global Tech Stocks

Summary iShares Exponential Technologies ETF focuses on companies driving technological innovation across various sectors, offering diversified exposure to high-growth potential industries. The ETF's investment thesis is centered on capturing the growth of exponential technologies, including AI, robotics, and biotechnology, which are expected to transform industries. The fund looks appealing due to its diversified portfolio, evidential capacity to out-perform (albeit not since January 2021), and alignment with long-term technological trends. At present, XT has clear potential for a high IRR, with the potential for returns of circa 11% annualized over the next five years. Read the full article on Seeking Alpha
Seeking Alpha • Jun 07

XT Will Likely Continue Lagging The Broader IT Sector

Summary iShares Exponential Technologies ETF is a hold due to multiple risk factors outweighing its returns along with a relatively high expense ratio. XT lacks holdings with strong fundamentals and diversified revenue streams compared to peer tech funds, particularly Vanguard's VGT. XT also includes foreign tech holdings in emerging markets, representing geopolitical risks. Read the full article on Seeking Alpha
Seeking Alpha • Mar 10

XT: Still Beating ARKK At Its Own Game, Upgrade To Buy For Possible Moonshot

Summary iShares Exponential Technologies ETF is a go-to holding due to market volatility and potential for high returns. I prefer XT to the ARK Innovation ETF, given its smoother path due to a more diversified and passive/indexed approach. XT's lower volatility and diversified portfolio make it a buy, with potential for a price increase to its 2022 high and beyond. Read the full article on Seeking Alpha
Seeking Alpha • Aug 07

XT: We're Going To Think Twice About This ETF

XT is pretty interesting and tackles an area of the market that has received flak in the latest sell-offs. However, we have some concerns about approaching emerging technologies with ETFs. Also the fund isn't that discounted despite expected reflexivity effects. Might get better bets with specific stocks. The iShares Exponential Technologies ETF (XT) might seem broadly interesting at first, but we have some misgivings about the concept of investing in ETFs of higher risk businesses. Moreover, we are surprised by how well the ETF has done all things considered, and worry that some latent effects might still hit it. Otherwise, we are pretty convinced of the appeal of tech in the current market, and feel that in general it should be studied by retail investors. But we would think twice about XT. Quick Breakdown First let's discuss some of the features of XT. The mandate is to build a portfolio that weights towards a decent amount of emerging markets and emerging technologies that follow nine key themes. XT Nine Areas of Focus (iShares.com) The themes listed above are pretty basic to be honest. We all know of the potential in these fields, and in the majority of cases the value of things like cloud computing have already been realised, at least in terms of priced in value, by large corporations through already profitable operations. Essentially, what XT is doing is allocating to all the sexiest ideas in investing that VCs would typically be focusing on. As mentioned it's not all US markets with only 62% allocation, which is nice because foreign markets typically don't value tech nearly as highly as the US does, and it's mostly tech but also some healthcare exposures, especially biotechs. The fee is below 0.5%, which isn't bad relative to some of these more 'exciting' ETFs. The fact sheet says that it's cheaper than 91% of ETFs in its category, but this should be taken with a grain of salt because they decide the categories. What matters is many iShares ETFs are around 0.4%, so just below 0.5% isn't bad relatively. ETFs and Exponential Technologies However, we have some comments about the ETF. The first is that the kinds of businesses it invests in, especially in healthcare, are stocks that depend reflexively on the equity capital market conditions. If their stocks decline, the cost of their financing rises. This is obviously bad because in unstable markets like the current one, where rates will have to rise a lot more to deal with inflation, because it causes vicious spirals.

Rentabilidad de los accionistas

XTUS Capital MarketsMercado US
7D2.3%4.1%2.2%
1Y30.8%12.4%24.8%

Rentabilidad vs. Industria: XT superó a la industria US Capital Markets, que obtuvo un rendimiento del 12.4% el año pasado.

Rentabilidad vs. Mercado: XT superó al mercado US, que obtuvo un rendimiento del 24.8% el año pasado.

Volatilidad de los precios

Is XT's price volatile compared to industry and market?
XT volatility
XT Average Weekly Movement3.1%
Capital Markets Industry Average Movement3.5%
Market Average Movement7.2%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.1%

Precio estable de las acciones: XT no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.

Volatilidad a lo largo del tiempo: La volatilidad semanal de XT (3%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
2015n/an/awww.ishares.com/us/products/272532/ishares-exponential-technologies-etf

iShares Trust - iShares Future Exponential Technologies ETF es un fondo cotizado en bolsa lanzado por BlackRock, Inc. El fondo está gestionado por BlackRock Fund Advisors. El fondo invierte en mercados de renta variable pública de la región global. El fondo invierte en acciones de empresas que operan en los sectores de las tecnologías de la información.

Resumen de fundamentos de iShares Trust - iShares Future Exponential Technologies ETF

¿Cómo se comparan los beneficios e ingresos de iShares Trust - iShares Future Exponential Technologies ETF con su capitalización de mercado?
Estadísticas fundamentales de XT
Capitalización bursátilUS$3.90b
Beneficios(TTM)US$0
Ingresos (TTM)n/a
n/a
Ratio precio-beneficio (PE)
n/a
Ratio precio-ventas (PS)

¿Está XT sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de XT
IngresosUS$0
Coste de los ingresosUS$0
Beneficio brutoUS$0
Otros gastosUS$0
BeneficiosUS$0

Últimos beneficios comunicados

n/a

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)0
Margen bruto0.00%
Margen de beneficio neto0.00%
Ratio deuda/patrimonio0.0%

¿Cómo se ha desempeñado XT a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

6.5%
Rentabilidad actual por dividendo
n/a
Ratio de pagos

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/06/16 08:48
Precio de las acciones al final del día2026/06/15 00:00
BeneficiosN/A
Ingresos anualesN/A

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

iShares Trust - iShares Future Exponential Technologies ETF está cubierta por 0 analistas. 0 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.